All In MedTech

Device Trial Radar · NCT05318105

Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Aquadex System in Patients With Heart Failure and Fluid Overload

Last checked: Nov 20, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 167 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

167

Actual

Start

Jun 28, 2022

Primary completion

Oct 6, 2025

Study completion Apr 7, 2026

Sponsor

Lead sponsor
Nuwellis, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 8, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The REVERSE-HF study is a randomized controlled trial to evaluate clinical outcomes of adjustable ultrafiltration with the Aquadex System as compared to adjustable IV loop diuretics in patients with worsening heart failure (HF) and fluid overload.

Conditions

  • Heart Failure (for Example, Fluid Overload)
  • Heart Failure
  • Fluid Overload

Interventions

  • Aquadex Smartflow® SystemDevice

    ultrafiltration

  • IV Loop DiureticsDrug

    diuretics

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first heart failure (HF) eventTime frame: within 30 days

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Banner Health

    Tucson, Arizona

  • MemorialCare, Long Beach Medical Center

    Long Beach, California

  • Sharp Memorial Hospital, San Diego Cardiac Center

    San Diego, California

12 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.